David Elsley, the President & CEO of Cardiol Therapeutics Inc. (Nasdaq: CRDL | TSX: CRDL), a company dedicated to healing the heart with innovative science, joins Vince Molinari to discuss their recent milestones to kick off 2024. Mr. Elsley shares the significance of Cardiol receiving the US FDA grant for Orphan Drug Designation for the company’s lead drug candidate, CardiolRx™, aimed at treating pericarditis, including recurrent pericarditis. He speaks to the severity of recurrent pericarditis, characterized by symptoms that significantly impact patients’ quality of life and physical activity. The FDA’s decision to grant ODD underscores the potential of CardiolRx™ to improve the lives of individuals suffering from this condition. They discuss Cardiol’s two ongoing Phase II clinical trials targeting rare diseases of recurrent pericarditis and acute myocarditis. Additionally, Mr. Elsley shares the market opportunity for the company’s potential treatment for heart failure – a leading cause of death and hospitalization in the developed world, with associated healthcare costs in the United States exceeding $30 billion annually.
Understanding ‘real world assets’ on the blockchain
Todd McDonald, Co-Founder and Chief Strategy Officer at R3, joins Remy Blaire to discuss understanding tokenization and real-world assets on the blockchain.
AtlasClear Holdings inc. – Aiming to create a more efficient platform for trading, and banking
John Schaible, Chief Strategy Officer at AtlasClear Holdings, inc., joins Vince Molinari to discuss ringing the opening bell and the future of the company. Atlas Clear aims to create a more efficient platform for trading, and banking.
Risks Bitcoin investors should be aware of
James Butterfill, Head of Research of CoinShares, joins Remy Blaire to discuss the Bitcoin price surge and the risks Bitcoin investors should be aware of.
Turning the smartphone into the earnphone
Dan Novaes, Chief Executive Officer at Mode Mobile, joins Vince Molinari to discuss how Mode Mobile created a state-of-the-art smartphone device with built-in earning features.
Wall Street Digests Inflation Data
Michael Reinking, Senior Market Strategist at the NYSE, provides insight into the U.S. inflation data and jobs report. Ahead of the March FOMC meeting, Reinking weighs in on event risk on the horizon.
Protecting retail traders in the stock market
Michael Warshowsky, CEO & Founder of Belay, joins Remy Blaire to discuss Belay. Belay was developed to help everyday traders protect their investments in the stock market.
ESG investing, BlackRock ETF, FetchAI
Mega-cap tech stocks make up bulk of ESG portfolios. Bitcoin rally pushed BlackRock ETF over $10 billion and FetchAI invests millions in Blockchain tech. Jane king with the latest from the Nasdaq.
Inside the ICE House, Episode 400: Professor Kenneth T. Jackson
Vince Molinari and Josh King, Chief Communications Officer at the Intercontinental Exchange (ICE) and Head of Corporate Affairs at the NYSE, discuss episode 400 of “Inside the ICE House” podcast, featuring Columbia University’s eminent Professor Kenneth T. Jackson. They also analyze New York City’s 400-year evolution from a Dutch colony into the beating heart of capitalism. Dr. Jackson explores the pivotal events, influential figures, and cultural shifts that have shaped the city’s rich history and discusses how its enduring legacy continues to impact its present and future. In addition, they drive down memory lane and look back at some of the guests who have graced the podcast.
Bitcoin Interest, Global Pollution, Blockchain Cloud
Bitcoin rally could mean the Federal Reserve will keep rates higher longer. Global carbon pollution hits record high and Nirvana Cloud debuts as blockchain-optimized alternative to AWS and Google. Jane King has the latest from the Nasdaq.